OTO-413

· Otonomy, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OTO-413, covering 2022-10-27 to 2022-10-27. Get the full timeline:

Most recent: Clinical Trial Update: OTO-413 in Subjects With Speech-in-Noise Hearing Impairment [Phase 1, Phase 2]